Trial Profile
A Phase 1b/2 Study of Repeat Radiation, Minocycline, and Bevacizumab in Patients With Recurrent Glioma.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Aug 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Minocycline (Primary)
- Indications Glioma
- Focus Adverse reactions
- Acronyms RAMBO
- 29 Nov 2018 Status changed from active, no longer recruiting to completed.
- 28 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 16 Aug 2016 Planned End Date changed from 1 Jul 2016 to 1 Aug 2020.